"I found a society I believed in, & my involvement has already been incredibly rewarding." - Michael Ayers, MD, FACC. Honor your deep dedication to excellence in CV care by advancing to FACC. To 🎉 summer, we are waiving all application fees! Apply now:

Primary LA cardiopathy seems to be associated with thrombotic events in ATTR-CM, independently of #AFib, CHA2DS2-VASc, and LA dilatation, unlike other left ventricular hypertrophy phenotypes. Read more: #JACCIMG @JACCJournals

Join the ACC & the @CardiacSociety in Dubai for #ACCMidEast (Oct 3-5)!. 🎯 Catch plenary sessions on #AI, obesity & more.🆕 On-Call With the Experts for real-time insights.👉 Learn more and register now: #ACCIntl #ACCEd

Science, networking and NYC in December! 🎄. Registration is now open for #FusterCVS, returning to New York City from Dec. 12-14! Join global experts and explore the latest in CV science. Secure your spot by Aug. 19 to lock in early bird pricing! 👉

Alpha-gal syndrome affects an estimated 500,000 individuals in the U.S. but remains significantly underrecognized & underdiagnosed. Learn about the cardiovascular implications of Alpha-Gal Syndrome, a tick-borne allergic condition in #CardiologyMag:

⏳ Deadline Approaching! The Hani Najm Global Scholar Award offers cardiologists from the Middle East & Africa an observership at a U.S. institution & an invitation to continue the learning at #ACC26 in New Orleans, with all 💰 paid!. Apply by July 14:

REDEFINE 1 & REDEFINE 2: The combination of CagriSema in a single weekly 💉 was associated w/ a significantly greater weight loss in adults w/ overweight or obesity regardless of T2D status compared w/ placebo or either drug alone. More: #CardioX.

Digital health technologies hold significant promise for addressing #CVD. How will these innovations move from concept to clinic? Read about current barriers to their widespread adoption & practical strategies to overcome them in #CardiologyMag. 🔗

CATALYST: Initiating DOACs within four days, rather than at 5️⃣ days or later, after an ischemic stroke in pts w/ #AFib reduced the risk of future stroke events within 30 days without increasing symptomatic intracerebral hemorrhage. Read more: #cvCoag.

The burden of #CVD from modifiable risk factors is ↗️ across Latin America & globally. Join us at #ACCLATAM for key sessions on #cvPrev:. ✅ #Hypertension.✅ Lipid Management.✅ Cardiometabolic Disease. Explore the agenda & start planning! #ACCIntl #ACCEd

From infographic to case challenge, explore tools that support BP monitoring in women at every stage of life w/ #ACCEd. Access 🆕 Activities on #Hypertension in Women:.🩺 Webinar by Dr. @GarimaVSharmaMD.📚 Case challenge.📥 Downloadable infographic.🔗

⏳ Deadline Approaching!. The William A. Zoghbi Global Research Initiative offers 7️⃣ awards of $25K each to support 🌍 cardiologists tackling #CVD & #cvPrev. Are you leading research that could 💫 care in your community?. Learn more & apply by July 14 ➡️

Catheter ablation was superior to a combination of lifestyle modification & antiarrhythmic drugs in improving freedom from #AFib at one year in patients w/ obesity, according to results from the PRAGUE-25 trial published in #JACC. Learn more: #cvEP

🚨 Closing Soon! Submit your abstract for #ACCCardioOB, Oct. 17–19 in Washington, DC!. 📢 Categories:.🔹 Original Research.🔹 Clinical Case Challenges.🔹 Professional Development. 📅 Deadline: July 8 at 11:59 p.m. ET.🔗 Submit now:

💡 Poll: 81 y/o w/ severe mitral stenosis from MAC, high surgical risk (STS > 8%), & a neo-LVOT too small for TMVR. What's the most reliable way to determine the size of the new THV & ↗️ the area of the neoLVOT?. Check the full case & vote 👉 #CardioX.

In a new activity developed through a collaboration w/ ACC & Medscape, learn how to identify, screen & diagnose patients w/ hypercortisolism as an underlying cause of resistant metabolic conditions. Learn more:

🏆 Congratulations to the 2025 #ChestPainMIRegistry Performance Achievement Award recipients!. This year, the ACC recognizes over 340 hospitals for submitting complete #cvAMI records to improve outcomes. 👏. Thank you for advancing CV care! 🔗 #NCDR #cvQI

In this #ACCEL Lite interview, Drs. @mmartinezheart and Barry Borlaug discuss “Hemodynamic Assessment for Diagnosis and Treatment Selection in #HFpEF.”. 🎧 Tune in here: #HeartFailure.

SWISS-APERO: At 3 years after left atrial appendage closure, there was no significant difference in the ischemic risk between the Amulet and the Watchman FLX groups. Learn more: #cvEP #JACC

In 👇 presentation, Pick Your Protocol: How to Test Your Athlete Patient, Dr. Benjamin D. Levine 🗣️ on how to best tailor appropriate tests for various types of athletic pts. Watch this session & more from #ACCAthleticHeart on #ACCAnywhere. #SportsCardio